Category: Articles
-
U.K Court Rules in Favor of Genentech in Parent Dispute
A U.K court has ruled that a drug manufactured by Regeneron Pharmaceuticals and Bayer to treat wet age-related macular degeneration breaches a European patent owned by Genentech, according Bloomberg in a wire report published online yesterday afternoon. According to the Bloomberg article, Tarrytown, New York-based Regeneron and Leverkusen, Germany-based Bayer had wanted the court not […]
-
StemCells Inc. Gets FDA Approval to Use Stem Cells from Aborted Babies in Macular Degeneration Trial
StemCells Inc. has been given permission from the U.S. Food and Drug Administration (FDA) to proceed with a controversial trial that will involve taking stem cells from babies that have been aborted and injecting these stem cells into the eyes macular degeneration sufferers, according to OneNewsNow. A recent report from OneNewsNow’s website indicated that StemCells’ […]
-
Early Detection Key To Managing Eye Illnesses
Vision impairment of some sort is commonplace for people over the age of 65, says a report from the St. Petersburg, Fla. based publication Patch. As we get older, our risk of deteriorating vision increases exponentially. Robin Quigg, an ophthalmic technician with the Eye Institute of West Florida, located in Largo, recommends yearly thorough eye […]
-
Little hope for macular degeneration cure, The Mirror assumes
In a report from the UK’s The Mirror from a few days ago (March 20, 2012), it is stated that there is no reliable cure for ARMD (age-related macular degeneration). According to The Mirror, ARMD affected almost 250,000 people in 2011. The condition is more prevalent in women, and is hereditary. It manifests as either […]